Accelerate Diagnostics Stock News

Nuveen Asset Management LLC boosted its position in shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) by 11.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 504,599 shares of the medical research companys stock after purchasing an additional 53,048 shares during the period. Nuveen Asset []

Related Stocks: OACB , SJR , SWKH , AXDX , ACBI , EBSB , GNOG , GSKY , FBC , SHSP , BWG , BPY , HUT , BTTR , LEGA ,

Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q3 2021 Results - Earnings Call Transcript

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 57.14% and -11.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s

SmileDirectClub and Accelerate Diagnostics are super cheap right now, with very high short positions. Here's why the shorts might rupture.

TUCSON, Ariz., Sept. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that it has entered into separate, privately negotiated exchange agreements with certain hold

Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q2 2021 Results - Earnings Call Transcript

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -2.86% and -12.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TUCSON, Ariz., July 15, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 5, 2021, at 4:30 p.m.

Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly.

TUCSON, Ariz., July 7, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the launch of a new IVD configuration of its Accelerate PhenoTest® BC kit in the United States.

TUCSON, Ariz., June 30, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that it will have 3 data presentations from its Improving Outcomes and Antibiotic Stewardship (

BEP, AXDX, FURY, KBAL, and LUNA have been added to the Zacks Rank #5 (Strong Sell) List on June 2, 2021

AXDX, CRIS, FSTR, GO, and PRLB have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2021